XML 55 R40.htm IDEA: XBRL DOCUMENT v3.7.0.1
Fair Value Measurement of Assets and Liabilities - Financial Assets and Liabilities Measured at Fair Value, Recurring (Details) - USD ($)
$ in Millions
Mar. 31, 2017
Dec. 31, 2016
Assets:    
Derivatives $ 107 $ 154
Liabilities:    
Derivatives 1  
Short-term Investments    
Assets:    
Investments 4,775 5,333
Long-term Investments    
Assets:    
Investments 4,421 3,851
Restricted cash | Short-term Investments    
Assets:    
Investments 20 19
Corporate debt securities | Short-term Investments    
Assets:    
Investments 4,687 5,246
Corporate debt securities | Long-term Investments    
Assets:    
Investments 4,421 3,851
Government and agency securities | Short-term Investments    
Assets:    
Investments 68 68
Recurring    
Assets:    
Cash and cash equivalents 1,979 1,816
Total financial assets 11,282 11,154
Recurring | Short-term Investments    
Assets:    
Investments 4,775 5,333
Recurring | Other Current Assets    
Assets:    
Derivatives 107 154
Recurring | Long-term Investments    
Assets:    
Investments 4,421 3,851
Recurring | Other Current Liabilities    
Liabilities:    
Derivatives 33 48
Recurring | Restricted cash | Short-term Investments    
Assets:    
Investments 20 19
Recurring | Corporate debt securities | Short-term Investments    
Assets:    
Investments 4,687 5,246
Recurring | Corporate debt securities | Long-term Investments    
Assets:    
Investments 4,421 3,851
Recurring | Government and agency securities | Short-term Investments    
Assets:    
Investments 68 68
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1)    
Assets:    
Cash and cash equivalents 1,979 1,816
Total financial assets 1,999 1,835
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Short-term Investments    
Assets:    
Investments 20 19
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Other Current Assets    
Assets:    
Derivatives 0 0
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Long-term Investments    
Assets:    
Investments 0 0
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Other Current Liabilities    
Liabilities:    
Derivatives 0 0
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Restricted cash | Short-term Investments    
Assets:    
Investments 20 19
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Corporate debt securities | Short-term Investments    
Assets:    
Investments 0 0
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Corporate debt securities | Long-term Investments    
Assets:    
Investments 0 0
Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Government and agency securities | Short-term Investments    
Assets:    
Investments 0 0
Recurring | Significant Other Observable Inputs (Level 2)    
Assets:    
Cash and cash equivalents 0 0
Total financial assets 9,283 9,319
Recurring | Significant Other Observable Inputs (Level 2) | Short-term Investments    
Assets:    
Investments 4,755 5,314
Recurring | Significant Other Observable Inputs (Level 2) | Other Current Assets    
Assets:    
Derivatives 107 154
Recurring | Significant Other Observable Inputs (Level 2) | Long-term Investments    
Assets:    
Investments 4,421 3,851
Recurring | Significant Other Observable Inputs (Level 2) | Other Current Liabilities    
Liabilities:    
Derivatives 33 48
Recurring | Significant Other Observable Inputs (Level 2) | Restricted cash | Short-term Investments    
Assets:    
Investments 0 0
Recurring | Significant Other Observable Inputs (Level 2) | Corporate debt securities | Short-term Investments    
Assets:    
Investments 4,687 5,246
Recurring | Significant Other Observable Inputs (Level 2) | Corporate debt securities | Long-term Investments    
Assets:    
Investments 4,421 3,851
Recurring | Significant Other Observable Inputs (Level 2) | Government and agency securities | Short-term Investments    
Assets:    
Investments $ 68 $ 68